Fulgent Genetics, Inc.
NASDAQ:FLGT
Overview | Financials
| Company Name | Fulgent Genetics, Inc. |
| Symbol | FLGT |
| Currency | USD |
| Price | 22.27 |
| Market Cap | 681,662,430 |
| Dividend Yield | 0% |
| 52-week-range | 14.57 - 23.56 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Mr. Ming Hsieh |
| Website | https://www.fulgentgenetics.com |
An error occurred while fetching data.
About Fulgent Genetics, Inc.
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD





